Sign in

CIK 0000875320

  • Large accelerated filer

VERTEX PHARMACEUTICALS INC / MA

Sign in to watch
Ticker
VRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MA
Entity type
Operating
EIN
043039129
Phone
+1 617-341-6393
Business address
50 NORTHERN AVENUE, BOSTON, MA, 02210
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$15,378,206
in 4 filings, $15.4M under 10b5-1 plans

Net −$15,378,206. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-03-10 WAGNER CHARLES F JR EVP & Chief Financial Officer Sale −185 $292.68 $54K 56,174
2023-03-10 WAGNER CHARLES F JR EVP & Chief Financial Officer Sale −27 $293.61 $8K 56,147
2023-03-10 WAGNER CHARLES F JR EVP & Chief Financial Officer Sale −102 $294.94 $30K 56,045
2023-02-27 Tatsis Ourania EVP, Chief Reg. & Quality Off. Sale −283 $287.20 $81K 56,876
2023-02-27 Tatsis Ourania EVP, Chief Reg. & Quality Off. Sale −51 $288.33 $15K 56,825
2023-02-27 Tatsis Ourania EVP, Chief Reg. & Quality Off. Sale −20 $289.29 $6K 56,805
2023-02-27 Arbuckle Stuart A EVP, COO Sale −3,834 $287.16 $1.1M 57,756
2023-02-27 Arbuckle Stuart A EVP, COO Sale −400 $287.59 $115K 57,356
2023-02-27 Arbuckle Stuart A EVP, COO Sale −800 $288.92 $231K 56,556
2023-02-27 Ambrose Kristen SVP & Chief Accounting Officer Sale −982 $287.25 $282K 7,528
2023-02-27 Ambrose Kristen SVP & Chief Accounting Officer Sale −183 $288.68 $53K 7,345
2023-02-27 Ambrose Kristen SVP & Chief Accounting Officer Sale −42 $289.63 $12K 7,303
2023-02-27 ALTSHULER DAVID EVP, Global Research and CSO Sale −3,636 $287.23 $1.0M 32,640
2023-02-27 ALTSHULER DAVID EVP, Global Research and CSO Sale −300 $288.74 $87K 32,340
2023-02-27 ALTSHULER DAVID EVP, Global Research and CSO Sale −302 $289.60 $87K 32,038
2023-02-24 WAGNER CHARLES F JR EVP & Chief Financial Officer Shares withheld for taxes −3,308 $289.12 $956K 58,133
2023-02-24 Tatsis Ourania EVP, Chief Reg. & Quality Off. Shares withheld for taxes −3,308 $289.12 $956K 57,159
2023-02-24 Sanna Bastiano EVP, Cell & Genetic Therapies Shares withheld for taxes −3,970 $289.12 $1.1M 52,014
2023-02-24 Sachdev Amit EVP, Chief Patient Officer Shares withheld for taxes −2,468 $289.12 $714K 66,518
2023-02-24 LEIDEN JEFFREY M Executive Chairman Shares withheld for taxes −13,730 $289.12 $4.0M 48,349

Page 33 of 40 · 781 trades